| AVSBX | VSMAX | AVSBX / VSMAX | |
| Total Expense Ratio | 0.00 | 0.05 | - |
| Annual Report Gross Expense Ratio | 0.25 | 0.05 | 500% |
| Fund Existence | 2 years | 26 years | - |
| Gain YTD | 27.821 | 18.860 | 148% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 162M | 183B | 0% |
| Annual Yield % from dividends | 1.14 | 1.21 | 94% |
| Returns for 1 year | 38.93 | 27.72 | 140% |
| Returns for 3 years | N/A | 52.01 | - |
| Returns for 5 years | N/A | 39.27 | - |
| Returns for 10 years | N/A | 160.78 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYOAX | 70.07 | 1.57 | +2.29% |
| Rydex Biotechnology H | |||
| HSCCX | 3.26 | 0.03 | +0.93% |
| Carillon Eagle Small Cap Growth C | |||
| GIEYX | 17.80 | 0.16 | +0.91% |
| GuideStone Funds International Eq Instl | |||
| EACOX | 21.86 | 0.17 | +0.78% |
| Eaton Vance Emerg & Frntr Countrs Eq A | |||
| VBIAX | 55.24 | 0.28 | +0.51% |
| Vanguard Balanced Index Adm | |||